Intravenous zanamivir for influenza myocarditis and enteral malabsorption
Main Authors: | Fritz-Patrick Jahns, Nawfel Ben-Hamouda, Matthias Kirsch, Aurélien Roumy, Lucas Liaudet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-018-2263-y |
Similar Items
-
Acute Fulminant Myocarditis Following Influenza Vaccination Requiring Extracorporeal Membrane Oxygenation
by: Youn-Jung Kim, et al.
Published: (2019-05-01) -
Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report
by: Maria Mazzitelli, et al.
Published: (2019-12-01) -
Extracorporeal Membrane Oxygenation for Fulminant Myocarditis: Increase of Cardiac Enzyme and SOFA Score Is Associated with High Mortality
by: Yun Im Lee, et al.
Published: (2021-04-01) -
Fulminant myocarditis managed with pulsatile extracorporeal life support; use of Twin Pulse Life support (T-PLS<sup>®</sup>)
by: Cho Eun, et al.
Published: (2011-11-01) -
L-T4 Therapy in Enteric Malabsorptive Disorders
by: Poupak Fallahi, et al.
Published: (2021-02-01)